Back
Roivant Sciences Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
44
ROIV
Roivant Sciences
Last Price:
$11.58
Seasonality Move:
-15.05%
Sell
26
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
$3.93
Seasonality Move:
-9.68%
Sell
44
Roivant Sciences (ROIV)
is a Sell
Is Roivant Sciences a Buy, Sell or Hold?
-
The current Roivant Sciences [ROIV] share price is $11.57. The Score for ROIV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
ROIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
-
The current Biodexa Pharmaceuticals PLC [BDRX] share price is $3.90. The Score for BDRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
BDRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ROIV Stock Price Chart
What is Roivant Sciences's stock price today?
-
The Roivant Sciences share price today is $11.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROIV is experiencing slight buying pressure.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $3.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
ROIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 41.56 | Sell |
Chaikin Money Flow: | 3262439 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.57 - 12.47) | Sell |
Bollinger Bands (100): | (11.23 - 12.21) | Sell |
BDRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 36.56 | Sell |
Chaikin Money Flow: | -21346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.85 - 5.31) | Sell |
Bollinger Bands (100): | (4.16 - 12.28) | Sell |
ROIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.86 | Sell |
20-day SMA: | 12.17 | Sell |
50-day SMA: | 11.89 | Sell |
200-day SMA: | 11.29 | Buy |
8-day EMA: | 11.82 | Sell |
20-day EMA: | 11.95 | Sell |
50-day EMA: | 11.89 | Sell |
200-day EMA: | 11.35 | Buy |
BDRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.16 | Sell |
20-day SMA: | 4.77 | Sell |
50-day SMA: | 5.23 | Sell |
200-day SMA: | 16.83 | Sell |
8-day EMA: | 4.19 | Sell |
20-day EMA: | 4.56 | Sell |
50-day EMA: | 5.73 | Sell |
200-day EMA: | 217.03 | Sell |
Roivant Sciences Earnings Growth & ROIV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.21 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Roivant Sciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biodexa Pharmaceuticals PLC Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |